Landscape Capital Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-6,775
Closed -$262K – 662
2025
Q1
$262K Sell
6,775
-13,336
-66% -$529K 0.02% 509
2024
Q4
$763K Sell
20,111
-29,703
-60% -$1.19M 0.08% 321
2024
Q3
$2.09M Sell
49,814
-5,674
-10% -$236K 0.21% 148
2024
Q2
$2.27M Buy
55,488
+31,023
+127% +$1.23M 0.19% 156
2024
Q1
$1.01M Sell
24,465
-8,735
-26% -$366K 0.09% 290
2023
Q4
$1.34M Buy
33,200
+27,532
+486% +$1.05M 0.12% 168
2023
Q3
$222K Sell
5,668
-6,051
-52% -$241K 0.03% 360
2023
Q2
$476K Buy
+11,719
New +$482K 0.06% 245

Other funds holding BME

Landscape Capital Management's BME Position: Q2 2025 in Review

Landscape Capital Management sold out of BlackRock Health Sciences Trust (BME) in Q2 2025, closing a stake of 6,775 shares — an estimated $262K sold.

Landscape Capital Management first reported a position in BME in Q2 2023 and held it in 8 quarters. The position peaked at $2.27M in Q2 2024. 72 funds tracked by Wall St. Rank hold BME as of Q2 2025.

  • Landscape Capital Management reported no remaining BlackRock Health Sciences Trust position as of Q2 2025 after selling out during the quarter.
  • Landscape Capital Management sold 6,775 BlackRock Health Sciences Trust shares in Q2 2025, an estimated $262K.
  • Landscape Capital Management first reported a position in BlackRock Health Sciences Trust in Q2 2023 and held it in 8 quarters.
  • Landscape Capital Management's BlackRock Health Sciences Trust position peaked at $2.27M in Q2 2024.
  • 72 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2025.

Based on Landscape Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.